1-18 of 18
Philip Caron, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline Sequential Immunochemotherapy Plus Lenalidomide for Mantle Cell Lymphoma Incorporating MRD Evaluation: Phase II, Investigator-Initiated, Single-Center Study

Zachary D. Epstein-Peterson, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Ahmet Dogan, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Caleb Ho, MD, Allison P. Jacob, Leana Laraque, BA, Matthew J Matasar, MD, Alison J. Moskowitz, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Colette Owens, MD, Gilles Salles, Heiko Schöder, MD, David J. Straus, MD, Anas Younes, Andrew D Zelenetz, MD PhD, Anita Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136565
Published: 2020
Journal Articles

CD5-Positive Marginal Zone Lymphoma: Clinical Characteristics of the MSKCC Cohort, and Comparison with the CD5-Negative Population

Paola Ghione, MD, Kurt S. Bantilan, MPH, Erel Joffe, MD MSc, M. Lia Palomba, MD, Ariela Noy, MD, Matthew J Matasar, MD, Philip Caron, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Anita Kumar, MD, Colette Owens, MD, Alison J. Moskowitz, MD, Lorenzo Falchi, MD, Gottfried von Keudell, MDPhD, Ildefonso Rodriguez-Rivera, MD, David J. Straus, MD, Steven M. Horwitz, MD, Ahmet Dogan, MD PhD, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50–51.
https://doi.org/10.1182/blood-2020-140757
Published: 2020
Journal Articles

Favorable Outcomes Among Patients with T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with Higher-Intensity Therapy in the Rituximab Era

Edith Tama Robin, MD, Esther Drill, DrPH, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Lorenzo Falchi, MD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Andrew M. Intlekofer, MD PhD, Erel Joffe, MD MSc, Anita Kumar, MD, Matthew J Matasar, MD, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, MD, Ildefonso Rodriguez-Rivera, MD, David J. Straus, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Andrew D Zelenetz, MD PhD, Craig H. Moskowitz, MD, Alison J. Moskowitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–38.
https://doi.org/10.1182/blood-2020-136489
Published: 2020
Journal Articles

Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, MD, Gunjan Shah, MD, Heiko Schöder, MD, Nivetha Ganesan, MPH, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Samia Sohail, BA, Alayna Santarosa, Lauren Pomerantz, BS, Christine Jarjies, MS, Natasha Galasso, BA, Rachel Neuman, Anita Kumar, MD, Oscar B Lahoud, MD, Connie Lee Batlevi, MDPhD, Paul A. Hamlin, MD, David J. Straus, MD, Ildefonso Rodriguez-Rivera, MD, Colette Owens, MD, Philip Caron, MD PhD, Andrew M. Intlekofer, MD PhD, Audrey Hamilton, MD, Steven M. Horwitz, MD, Lorenzo Falchi, MD, Erel Joffe, MD MSc, Maria Lia Palomba, Ariela Noy, MD, Matthew J Matasar, MD, Georgios Pongas, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Joachim Yahalom, MD, Andrew D Zelenetz, MD PhD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-138434
Published: 2020
Journal Articles

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, MD, Jason Westin, MD, Stephen J Schuster, MD, Grzegorz S. Nowakowski, MD, Izidore S. Lossos, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Allison P. Jacob, Erel Joffe, MD MSc, Ashlee Joseph, Gottfried R. von Keudell, MD PhD, Leana Laraque, BA, Oscar B Lahoud, MD, Matthew J Matasar, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, Carol S. Portlock, MD, Ildefonso Rodriguez-Rivera, MD, Gilles Salles, MDPhD, Venkatraman Seshan, PhD, David J. Straus, MD, Shreya Vemuri, Anas Younes, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138889
Published: 2020
Journal Articles

Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era

Sabela Bobillo, MD, Erel Joffe, MDMSc, Venkatraman Seshan, PhD, Ariela Noy, MD, Steven M. Horwitz, MD, M. Lia Palomba, MD, Matthew J Matasar, MD, David J. Straus, MD, Paul A. Hamlin, MD, Connie Lee Batlevi, MD PhD, Paola Ghione, MD, David Sermer, MD, Alison J. Moskowitz, MD, Audrey Hamilton, MD, Philip Caron, MD PhD, Colette Owens, MD, Gottfried R. von Keudell, MD PhD, Ahmet Dogan, MD PhD, Andrew D. Zelenetz, MD PhD, Anas Younes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1619.
https://doi.org/10.1182/blood-2019-131435
Published: 2019
Journal Articles

Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Jake R. Schade, BA, Charles Kim, MD, Esther Drill, PhD, Annie Qiu, BA, Connie Lee Batlevi, MD PhD, Philip Caron, MD PhD, Donald Steven Colbourn, MD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Andrew M. Intlekofer, MD PhD, Erel Joffe, MDMSc, Gottfried R. von Keudell, MD PhD, Anita Kumar, MD, Ariela Noy, MD, Michelle Okwali, MPH, Colette Owens, MD, M. Lia Palomba, MD, Ildefonso Rodriguez-Rivera, MD, Craig S. Sauter, MD, Heiko Schoder, MD, David J. Straus, MD, Santosha Vardhana, MD PhD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Matthew J Matasar, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2904.
https://doi.org/10.1182/blood-2019-122760
Published: 2019
Journal Articles

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, Ranjana H Advani, MD, Lihua E Budde, MD PhD, Paul M. Barr, MD, Connie Lee Batlevi, MD PhD, Philip Caron, MD PhD, Louis S. Constine, MD, Savita Dandapani, MD PhD, Esther Drill, PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, Clare Grieve, BA, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T Hoppe, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, Susan Jennifer McCall, NP, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Heiko Schoder, MD, David J. Straus, MD, Shreya Vemuri, Joanna C Yang, MD MPH, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Joachim Yahalom, MD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2834.
https://doi.org/10.1182/blood-2019-123150
Published: 2019
Journal Articles

High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed and Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, MD, Gunjan L. Shah, MDMS, Heiko Schoder, MD, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Christopher Joong, BS, Lauren Pomerantz, BS, Christine Jarjies, MS, Anita Kumar, MD, Oscar B Lahoud, MD, Connie Lee Batlevi, MD PhD, Paul A. Hamlin, MD, David J. Straus, MD, Ildefonso Rodriguez-Rivera, MD, Colette Owens, MD, Philip Caron, MD PhD, Donald Steven Colbourn, MD, Andrew M. Intlekofer, MD PhD, Audrey Hamilton, MD, Steven M. Horwitz, MD, Erel Joffe, MDMSc, M. Lia Palomba, MD, Ariela Noy, MD, Matthew J Matasar, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Joachim Yahalom, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2837.
https://doi.org/10.1182/blood-2019-127575
Published: 2019
Journal Articles

Initial Results of a Phase II Study of Sequential Chemotherapy and Lenalidomide Followed By Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

Anita Kumar, MD, Andrew D. Zelenetz, MD PhD, Connie Lee Batlevi, MD, Philip Caron, MD PhD, Ahmet Dogan, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Leana Laraque, BA, Matthew J Matasar, Susan Jennifer McCall, NP, Alison J. Moskowitz, MD, Craig H. Moskowitz, MD, Colette Owens, MD, Janine Pichardo, Heiko Schoder, MD, Allison Sigler, David J. Straus, MD, Anas Younes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2880.
https://doi.org/10.1182/blood-2018-99-120069
Published: 2018
Journal Articles

A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, MD, Ranjana H. Advani, MD, Lihua Budde, MD PhD, Paul M. Barr, MD, Connie L. Batlevi, MD PhD, Philip Caron, MD PhD, Robert W. Chen, MD, Louis S. Constine, MD, Amanda Courtien, Savita Dandapani, MD PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T. Hoppe, MD, Steven M. Horwitz, MD, Matthew J. Matasar, MD, Shoshana T. Miller, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria L. Palomba, MD, Carol S. Portlock, MD, Heiko Schoder, MD, David J. Straus, MD, Joanna C. Yang, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Joachim Yahalom, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 734.
https://doi.org/10.1182/blood.V130.Suppl_1.734.734
Published: 2017
Journal Articles

Active Surveillance for Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Sven Borchmann, Erel Joffe, MDMSc, Craig H. Moskowitz, MD, Andrew D. Zelenetz, MD PhD, Ariela Noy, MD PhD, Carol S Portlock, MD, John F Gerecitano, MD PhD, Connie Batlevi, MD PhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Anita Kumar, MD, Matthew J. Matasar, MD MS, Alison J. Moskowitz, MD, Colette N Owens, MD BA, Lia Palomba, MD, Anas Younes, MD, David J. Straus, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 654.
https://doi.org/10.1182/blood.V130.Suppl_1.654.654
Published: 2017
Journal Articles

Impact of PET Staging of Follicular Lymphoma on Treatment Outcomes and Prognosis

Anna Alperovich, MD, Connie L. Batlevi, MD PhD, Andrew M Intlekofer, MD PhD, Craig H. Moskowitz, MD, Steven M. Horwitz, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Palomba, MD, Alison J. Moskowitz, MD, John Gerecitano, MD PhD, Paul A. Hamlin, MD, Matthew J. Matasar, MD, Craig S. Sauter, MD, Anita Kumar, MD, Ariela Noy, MD, David J. Straus, MD, Carol S. Portlock, MD, Audrey Hamilton, MD, Pamela Drullinsky, MD, Philip Caron, MD PhD, Ai Ni, PhD, Venkatraman Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1494.
https://doi.org/10.1182/blood.V130.Suppl_1.1494.1494
Published: 2017
Journal Articles

Intervention Versus Observation: What Is the Appropriate Endpoint? Assessment of Endpoints in Patients with Advanced Stage Follicular Lymphoma Who Are Initially Observed

Jacob D Soumerai, MD, Kurt S Bantilan, MPH, Ai Ni, PhD, Connie Batlevi, MD PhD, Anna Alperovich, MD, Katy Smith, MBChB BSc, Zhitao Ying, MD, Amanda R Copeland, RN, MSN, CNS, Matthew J. Matasar, MD MS, David J Straus, MD, John F Gerecitano, MD PhD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Carol S Portlock, MD, Maria Lia Palomba, MD, Craig H Moskowitz, MD, Alison J Moskowitz, MD, Ariela Noy, MD PhD, Craig S Sauter, MD, Anita Kumar, MD, Andrew M Intlekofer, MD PhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, Anas Younes, MD, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1777.
https://doi.org/10.1182/blood.V128.22.1777.1777
Published: 2016
Journal Articles

Benchmark of Progression Free Survival for Multiple Lines of Therapy in Follicular Lymphoma Treated in the Rituximab Era

Anna Alperovich, MD, Connie Batlevi, MD PhD, Katy Smith, MBBS, MRCP, Zhitao Ying, MD, Jacob D Soumerai, MD, Amanda R Copeland, RN, MSN, CNS, Erel Joffe, MDMSc, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Andrew M Intlekofer, MD PhD, Anita Kumar, MD, Matthew J Matasar, MD MS, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S Portlock, MD, Craig S Sauter, MD, David J Straus, MD, Andrew D. Zelenetz, MD PhD, Ai Ni, PhD, Venkatraman E Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 2955.
https://doi.org/10.1182/blood.V128.22.2955.2955
Published: 2016
Journal Articles

Outcomes of Follicular Lymphoma Patients By Dynamic FLIPI at Diagnosis and Initial Treatment in the Post-Rituximab Era

Connie Batlevi, MD PhD, Anna Alperovich, MD, Katy Smith, MBChB BSc, Zhitao Ying, MD, Jacob D Soumerai, MD, Amanda R Copeland, RN, MSN, CNS, Erel Joffe, MD MSc, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Andrew M Intlekofer, MD PhD, Anita Kumar, MD, Matthew J. Matasar, MD MS, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S Portlock, MD, Craig S Sauter, MD, David J Straus, MD, Andrew D. Zelenetz, MD PhD, Ai Ni, PhD, Venkatraman E Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 4119.
https://doi.org/10.1182/blood.V128.22.4119.4119
Published: 2016
Journal Articles

Greater Total Dose and Duration of Treatment with Bortezomib Are Associated with Higher Incidence of Chalazion and Other Ocular Side Effects

Karuna Ganesh, MBBChir, PhD, Connie Batlevi, MD PhD, Zhigang Zhang, PhD, Hani Hassoun, MD, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Craig H. Moskowitz, MD, Philip Caron, MD PhD, Robert Motzer, MD, Sergio A Giralt, MD, Paul Hamlin, MD, Stuart M. Lichtman, MD, Matthew J. Matasar, MD MS, Carol S Portlock, MD, Neerav Shukla, MD, Carol Wasserheit-Lieblich, MD, Andrew D. Zelenetz, MD PhD, John F. Gerecitano, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3487.
https://doi.org/10.1182/blood.V124.21.3487.3487
Published: 2014
Journal Articles

Safety and Early Efficacy in an Ongoing Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 30 Gray Involved-Site Radiotherapy for Newly Diagnosed, Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Joachim Yahalom, MD, Heiko Schoder, MD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F. Gerecitano, MD PhD, Audrey Hamilton, MD, Paul Hamlin, MD, Steven M. Horwitz, MD, Alexandra G. Jacob, BS, Matthew J. Matasar, MD MS, Susan McCall, Alison J Moskowitz, MD, Ariela Noy, Lia Palomba, MD, Carol S Portlock, MD, David J. Straus, MD, Stephanie Verwys, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Anas Younes, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2014) 124 (21): 3085.
https://doi.org/10.1182/blood.V124.21.3085.3085
Published: 2014